Invention Grant
- Patent Title: Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
-
Application No.: US16324596Application Date: 2017-08-10
-
Publication No.: US10414774B2Publication Date: 2019-09-17
- Inventor: Jared N. Cumming , Kevin D. Dykstra , Alan Hruza , Derun Li , Hong Liu , Haiqun Tang , Brandon M. Taoka , Andreas Verras , Shawn P. Walsh , Wen-Lian Wu
- Applicant: Merck Sharp & Dohme Corp. , Jared N. Cumming , Kevin D. Dykstra , Alan Hruza , Derun Li , Hong Liu , Haiqun Tang , Brandon M. Taoka , Andreas Verras , Shawn P. Walsh , Wen-Lian Wu
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Janet E. Fair; Catherine D. Fitch
- International Application: PCT/US2017/046186 WO 20170810
- International Announcement: WO2018/034918 WO 20180222
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61P3/10 ; C07D498/04 ; C07D513/04 ; C07D471/04
Abstract:
Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.
Public/Granted literature
Information query
